Barron’s still likes MDT—even at its much higher valuation: https://www.barrons.com/articles/another-reason-to-like-medtronic-shares-51573870541 This write-up features the Micra pacemaker. The previous Barron’s write-up on MDT was in Aug 2017 (#msg-134152817). The stock is up 48% since then.